Journal article
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient
Future oncology (London, England), Vol.16(1S), pp.33-38
01/01/2020
DOI: 10.2217/fon-2019-0600
PMID: 31975628
Abstract
We report the case of a heavily pretreated male subject affected by left funiculus liposarcoma and successfully treated with eribulin mesylate. After three surgical interventions, radiotherapy on the lesion of the penile bulb for satellite nodules and an epirubicin + ifosfamide chemotherapy treatment for six cycles, eribulin was administered at the dose of 1.1 mg/m(2) on days 1 and 8, every 3 weeks for a total of nine cycles. A significant reduction of the lesions was achieved after four cycles of therapy, with a good profile of tolerability.
Details
- Title: Subtitle
- A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient
- Creators
- Salvatora Tindara Miano - University of SienaEdoardo Francini - Ospedale Misericordia - GrossetoRoberto Petrioli - University of SienaGuido Francini - University of Siena
- Resource Type
- Journal article
- Publication Details
- Future oncology (London, England), Vol.16(1S), pp.33-38
- DOI
- 10.2217/fon-2019-0600
- PMID
- 31975628
- ISSN
- 1479-6694
- eISSN
- 1744-8301
- Publisher
- Taylor & Francis
- Number of pages
- 6
- Grant note
- Eisai; Eisai Co Ltd
- Language
- English
- Date published
- 01/01/2020
- Academic Unit
- Internal Medicine
- Record Identifier
- 9985221142302771
Metrics
1 Record Views